Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for 00627_FLUKA

    Client Email Product

    00627_FLUKA

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    16
    US DMFs Filed

    US DMFs Filed

    12
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    4
    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    5
    API REF. PRICE (USD / KG)
    34

    API Market Place

    15
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    65
    Europe

    Europe

    14
    Canada

    Canada

    8
    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    10
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1.00

    Annual Reports

    0

    FDF Market Place

    6
    EXCIPIENTS
    151
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    4

    USFDA Exclusivities

    1
    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    42
    REF STANDARD

    EDQM

    0

    USP

    1

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    left grey arrow
    right gray arrow
    • SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 10GM/20ML (500MG/ML)
    • SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 1GM/2ML (500MG/ML)
    • SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 25GM/50ML (500MG/ML)
    • SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 5GM/10ML (500MG/ML)
    • POWDER;ORAL - 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT
    Full View ScreenFull Screen View
    Taro Pharma's Generic Magnesium Sulfate Receives Approval in the U.S
    Taro Pharma's Generic Magnesium Sulfate Receives Approval in the U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206431

    FDA
    19 Mar 2024
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Cupric Sulfate, Magnesium Sulfate, Selenious Acid, Zinc Sulfate Injection
    FDA Confirms Paragraph IV Patent Litigation for Cupric Sulfate, Magnesium Sulfate, Selenious Acid, Zinc Sulfate Injection

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-cupric-sulfate-magnesium-sulfate-selenious-acid-zinc-sulfate-injection-87595.pdf

    FDA
    10 Jan 2024
    Share Share
    Alkem Lab's Generic Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Receives Approval in the U.S.
    Alkem Lab's Generic Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213924

    FDA
    29 Dec 2023
    Share Share
    Strides Pharma's Generic Sodium Sulfate, Potassium Sulfate & Magnesium Sulfate Receives Approval in the U.S.
    Strides Pharma's Generic Sodium Sulfate, Potassium Sulfate & Magnesium Sulfate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215469

    FDA
    22 Nov 2023
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Sodium Sulfate, Magnesium Sulfate and Potassium Chloride
    FDA Confirms Paragraph IV Patent Litigation for Sodium Sulfate, Magnesium Sulfate and Potassium Chloride

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-sodium-sulfate-magnesium-sulfate-and-potassium-chloride-91224.pdf

    FDA
    25 Apr 2023
    Share Share
    Milla and the Alter Announce Launch of a Generic Version of Magnesium Sulfate
    Milla and the Alter Announce Launch of a Generic Version of Magnesium Sulfate

    https://www.businesswire.com/news/home/20230320005186/en

    BUSINESSWIRE
    20 Mar 2023
    Share Share
    Lupin gets US FDA approval for generic used to cleanse colon
    Lupin gets US FDA approval for generic used to cleanse colon

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-us-fda-approval-for-generic-used-to-cleanse-colon/articleshow/94091269.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    09 Sep 2022
    Share Share
    Stride Pharma's Generic Na, K and Mg Sulfate Receives Approval in the U.S.
    Stride Pharma's Generic Na, K and Mg Sulfate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215469

    FDA
    06 Jan 2022
    Share Share
    PTS Consulting’s Generics Aztreonam Receives Approvals In US
    PTS Consulting’s Generics Aztreonam Receives Approvals In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209642

    FDA
    10 Nov 2021
    Share Share
    Milla Pharma Announces Approval of a Generic Version of Magnesium Sulfate
    Milla Pharma Announces Approval of a Generic Version of Magnesium Sulfate

    https://www.businesswire.com/news/home/20211109005804/en/Milla-Pharmaceuticals-Inc.-Announces-Approval-of-a-Generic-Version-of-Magnesium-Sulfate-in-Water-for-Injection-in-Non-PVC-Single-Patient-Use-Containers

    BUSINESSWIRE
    09 Nov 2021
    Share Share
    Annora Pharma's Generic Sodium Sulfate;Potassium Sulfate;Magnesium Sulfate Receives Approval In US
    Annora Pharma's Generic Sodium Sulfate;Potassium Sulfate;Magnesium Sulfate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212903

    FDA
    15 Jun 2021
    Share Share
    Baxter Healthcare`s Magnesium Sulfate Receives Approval in US
    Baxter Healthcare`s Magnesium Sulfate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211965

    FDA
    15 Aug 2020
    Share Share
    Gland Pharma`s Generic Magnesium Sulfate Receives Approval in US
    Gland Pharma`s Generic Magnesium Sulfate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213917

    FDA
    16 Jul 2020
    Share Share
    Baxter Healthcare`s Generic Magnesium Sulfate Receives Approval in US
    Baxter Healthcare`s Generic Magnesium Sulfate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211966

    FDA
    04 Jun 2020
    Share Share
    Magnesium sulfate: risk of skeletal adverse effects in the neonate
    Magnesium sulfate: risk of skeletal adverse effects in the neonate

    https://www.gov.uk/drug-safety-update/magnesium-sulfate-risk-of-skeletal-adverse-effects-in-the-neonate-following-prolonged-or-repeated-use-in-pregnancy

    MHRA
    17 May 2019
    Share Share
    Enforcement Report - Week of May 1, 2019
    Enforcement Report - Week of May 1, 2019

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-May-1-2019-1556686753.pdf

    FDA
    01 May 2019
    Share Share
    Taro Pharm's Generic Sodium Sulfate;Potassium Sulfate;Magnesium Sulfate in US
    Taro Pharm's Generic Sodium Sulfate;Potassium Sulfate;Magnesium Sulfate in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206431

    FDA
    31 Oct 2018
    Share Share
    Enforcement Report - Week of October 17, 2018
    Enforcement Report - Week of October 17, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-17-2018-1539751948.pdf

    FDA
    17 Oct 2018
    Share Share
    Mylan Labs' Generic Magnesium Sulfate Receives Approval in US
    Mylan Labs' Generic Magnesium Sulfate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209932

    FDA
    14 Sep 2018
    Share Share
    Enforcement Report - Week of August 15, 2018
    Enforcement Report - Week of August 15, 2018

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-15-2018-1534336681.pdf

    FDA
    15 Aug 2018
    Share Share
    Hq Spclt Pharma Generic Magnesium Sulfate Receives Approval In Us
    Hq Spclt Pharma Generic Magnesium Sulfate Receives Approval In Us

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207350

    FDA
    12 Dec 2017
    Share Share
    Enforcement Report - Week of November 1, 2017
    Enforcement Report - Week of November 1, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2017-1509512060.pdf

    FDA
    01 Nov 2017
    Share Share
    Enforcement Report - Week of August 2, 2017
    Enforcement Report - Week of August 2, 2017

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-2-2017-1501649040.pdf

    FDA
    02 Aug 2017
    Share Share
    Anvisa Suspends Samtec Biotecnologia Ltda Magnesium Sulphate
    Anvisa Suspends Samtec Biotecnologia Ltda Magnesium Sulphate

    https://www.pharmacompass.com/pdf/news/anvisa-suspends-samtec-biotecnologia-ltda-magnesium-sulphate-1500615120.pdf

    ANVISA
    20 Jul 2017
    Share Share
    Anivisa Prohibits Supplements and Irregular Medications
    Anivisa Prohibits Supplements and Irregular Medications

    https://www.pharmacompass.com/pdf/news/anivisa-prohibits-supplements-and-irregular-medications-1500529438.pdf

    ANVISA
    19 Jul 2017
    Share Share
    Enforcement Report - Week of June 7, 2017
    Enforcement Report - Week of June 7, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2017-1496811142.pdf

    FDA
    07 Jun 2017
    Share Share
    Braintree Laboratories, Inc. v. Breckenridge Pharmaceutical, Inc.
    Braintree Laboratories, Inc. v. Breckenridge Pharmaceutical, Inc.

    http://www.patentdocs.org/2017/05/braintree-laboratories-inc-v-breckenridge-pharmaceutical-inc-fed-cir-2017.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+PatentDocs+%28Patent+Docs%29

    PRESS RELEASE
    05 May 2017
    Share Share
    Novel's Generic Magnesium Sulfate; Potassium Sulfate Receives Approval In US
    Novel's Generic Magnesium Sulfate; Potassium Sulfate Receives Approval In US

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202511

    FDA
    23 Feb 2017
    Share Share
    Breckenridge's Generic Sodium Sulfate, Magnesium Sulfate & Potassium Sulfate Receives Approval In US
    Breckenridge's Generic Sodium Sulfate, Magnesium Sulfate & Potassium Sulfate Receives Approval In US

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204135

    FDA
    17 Nov 2016
    Share Share
    Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep
    Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep

    http://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-generic-version-of-suprep-oral-solution-and-confirms-patent-challenge-for-generic-version-of-mirvaso-gel-300316991.html

    PR NEWSWIRE
    23 Aug 2016
    Share Share
    US FDA Enforcement Report- 25/May/2016
    US FDA Enforcement Report- 25/May/2016

    https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-25may2016-1464178748.pdf

    FDA
    24 May 2016
    Share Share
    Hospira Issues A Voluntary Recall For One Lot Of 50% Magnesium Sulfate Inj
    Hospira Issues A Voluntary Recall For One Lot Of 50% Magnesium Sulfate Inj

    http://www.fda.gov/Safety/Recalls/ucm496111.htm

    FDA
    13 Apr 2016
    Share Share
    Fresenius Kabi Usa's Generic Magnesium Sulfate in plastic container approves in US for prevention, control of seizures in preeclampsia
    Fresenius Kabi Usa's Generic Magnesium Sulfate in plastic container approves in US for prevention, control of seizures in preeclampsia

    https://www.pharmacompass.com/pdf/news/fresenius-kabi-usas-generic-magnesium-sulfate-in-plastic-container-approves-in-us-for-prevention-control-of-seizures-in-preeclampsia-1458722673.pdf

    FDA
    15 Mar 2016
    Share Share
    Fresenius Kabi Usa's Generic Magnesium Sulfate In Dextrose 5% approved in US for prevention, control of seizures in preeclampsia
    Fresenius Kabi Usa's Generic Magnesium Sulfate In Dextrose 5% approved in US for prevention, control of seizures in preeclampsia

    https://www.pharmacompass.com/pdf/news/fresenius-kabi-usas-generic-magnesium-sulfate-in-dextrose-5-approved-in-us-for-prevention-control-of-seizures-in-preeclampsia-1457777024.pdf

    FDA
    07 Mar 2016
    Share Share
    Hospira Inc. recalls Magnesium Sulfate in Water for Injection due to Incorrect Barcode
    Hospira Inc. recalls Magnesium Sulfate in Water for Injection due to Incorrect Barcode

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0668-2016&w=02242016&lang=eng

    FDA
    24 Feb 2016
    Share Share
    PQ Corporation recalls Epsom Salt(Magnesium Sulfate Heptahydrate) due to failed impurities
    PQ Corporation recalls Epsom Salt(Magnesium Sulfate Heptahydrate) due to failed impurities

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0564-2016&w=01132016&lang=eng

    FDA
    13 Jan 2016
    Share Share
    Hospira Issues Voluntary Nationwide Recall of One Lot of Magnesium Sulfate
    Hospira Issues Voluntary Nationwide Recall of One Lot of Magnesium Sulfate

    http://www.fda.gov/Safety/Recalls/ucm480163.htm

    FDA
    06 Jan 2016
    Share Share
    Hospira Initiates Class I Recall of Magnesium Sulfate in 5% Dextrose Injection
    Hospira Initiates Class I Recall of Magnesium Sulfate in 5% Dextrose Injection

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1076-2015&w=05202015&lang=eng

    FDA
    21 May 2015
    Share Share
    Drug shortages become issue in Teva and Mylan hook-up
    Drug shortages become issue in Teva and Mylan hook-up

    http://www.fiercepharmamanufacturing.com/story/drug-shortages-becomes-issue-teva-and-mylan-hook/2015-04-30

    Eric Palmer FIERCE PHARMA MANUFACTURING
    30 Apr 2015
    Share Share
    FDA Drug Shortages: Magnesium Sulfate Injection
    FDA Drug Shortages: Magnesium Sulfate Injection

    http://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Magnesium+Sulfate+Injection&source=govdelivery&st=c&tab=tabs-4&utm_medium=email&utm_source=govdelivery

    FDA
    25 Mar 2015
    Share Share
    Hospira Issues a Voluntary Nationwide Recall of One Lot of Magnesium Sulfate in 5% Dextrose Injection Due to Incorrect Barcode Labeling Photo
    Hospira Issues a Voluntary Nationwide Recall of One Lot of Magnesium Sulfate in 5% Dextrose Injection Due to Incorrect Barcode Labeling Photo

    http://www.fda.gov/Safety/Recalls/ucm437036.htm

    FDA
    10 Mar 2015
    Share Share
    Walgreens Infusion Services, Ongoing Class II recall of Magnesium sulfate various strengths in sodium chloride because of Lack of sterility assurance.
    Walgreens Infusion Services, Ongoing Class II recall of Magnesium sulfate various strengths in sodium chloride because of Lack of sterility assurance.

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0369-2015&w=01282015&lang=eng

    FDA
    28 Jan 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search